Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q8TB73

Entry ID Method Resolution Chain Position Source
AF-Q8TB73-F1 Predicted AlphaFoldDB

451 variants for Q8TB73

Variant ID(s) Position Change Description Diseaes Association Provenance
rs1727077385
RCV001034704
62 K>* Hypogonadotropic hypogonadism 25 with anosmia [ClinVar] Yes ClinVar
dbSNP
VAR_084037 62 K>del HH25; loss of protein expression [UniProt] Yes UniProt
rs1726901153
RCV001034705
128 Y>missing Hypogonadotropic hypogonadism 25 with anosmia [ClinVar] Yes ClinVar
dbSNP
rs200466645
VAR_084038
CA3061747
201 T>S HH25; no effect on protein abundance; no effect on function in cellular response to fibroblast growth factor stimulus [UniProt] Yes ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
RCV001034706
rs1726871489
469 W>* Hypogonadotropic hypogonadism 25 with anosmia [ClinVar] Yes ClinVar
dbSNP
VAR_084039 469 W>del HH25; no effect on protein abundance; decreased secretion; loss of function in cellular response to fibroblast growth factor stimulus [UniProt] Yes UniProt
rs749842184
CA3061890
2 V>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 5 H>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358217184
rs1425613951
6 W>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3061887
rs748156175
11 L>F No ClinGen
ExAC
TOPMed
gnomAD
rs1579312837
CA358217143
12 L>P No ClinGen
Ensembl
CA3061886
rs781487653
14 P>T No ClinGen
ExAC
gnomAD
rs1266608820
CA358217127
15 L>V No ClinGen
gnomAD
rs751398295
CA3061884
17 S>T No ClinGen
ExAC
gnomAD
CA358217106
rs1207248293
18 R>T No ClinGen
Ensembl
TCGA novel 20 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 20 Q>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1309440977
CA358217088
21 K>E No ClinGen
gnomAD
rs765264077
CA3061880
24 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs202087102
CA105147788
COSM1198846
25 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
COSM447297
rs994851514
CA105147789
25 R>W Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
CA358217056
rs1560605319
26 D>H No ClinGen
Ensembl
CA358217049
rs1406153824
27 E>K No ClinGen
gnomAD
CA358217022
rs1463875372
30 F>C No ClinGen
gnomAD
CA358217019
rs1355867475
31 Q>K No ClinGen
gnomAD
CA358217015
rs1170720479
31 Q>R No ClinGen
gnomAD
CA358217006
rs1426667729
32 M>R No ClinGen
gnomAD
CA3061876
CA358216998
rs760205671
33 Q>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs763830421
CA3061878
33 Q>P No ClinGen
ExAC
gnomAD
CA3061877
rs763830421
33 Q>R No ClinGen
ExAC
gnomAD
CA3061875
rs368314253
35 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1175215245
CA358216987
35 R>L No ClinGen
gnomAD
rs1175215245
CA358216988
35 R>P No ClinGen
gnomAD
COSM1050519
rs1175215245
CA358216989
35 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA358216990
rs368314253
35 R>W No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA358216982
rs1238486549
36 D>G No ClinGen
TOPMed
rs1481500594
CA358216977
37 K>E No ClinGen
gnomAD
rs771340831
CA358216969
38 A>S No ClinGen
ExAC
TOPMed
gnomAD
COSM1731983
CA3061874
rs771340831
38 A>T NS [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
CA3061873
rs763298175
38 A>V No ClinGen
ExAC
gnomAD
CA358216955
rs1579312722
40 F>C No ClinGen
Ensembl
TCGA novel 40 F>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773710298
CA3061872
41 H>L No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 41 H>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs773710298
CA358216947
41 H>P No ClinGen
ExAC
TOPMed
gnomAD
CA105147787
rs770226517
43 S>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
TCGA novel 43 S>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061871
rs770226517
43 S>W No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 44 S>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1393438550
CA358216921
45 V>A No ClinGen
gnomAD
CA3061868
rs768753287
49 G>E No ClinGen
ExAC
gnomAD
rs747249016
CA3061867
50 A>G No ClinGen
ExAC
gnomAD
rs1359224302
CA358216882
51 E>D No ClinGen
gnomAD
TCGA novel 52 I>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs540385907
CA3061866
52 I>T No ClinGen
1000Genomes
ExAC
gnomAD
CA358216879
rs1403230080
52 I>V No ClinGen
gnomAD
rs1481960954
CA358216871
53 S>N No ClinGen
TOPMed
rs1579312684
CA358216868
53 S>R No ClinGen
Ensembl
CA358216859
rs1469887047
54 S>R No ClinGen
gnomAD
CA358216857
rs1363099545
55 Y>H No ClinGen
gnomAD
rs1579312676
CA358216849
56 L>V No ClinGen
Ensembl
CA105147785
rs994141874
59 D>G No ClinGen
TOPMed
TCGA novel 59 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750176882
CA3061864
60 T>A No ClinGen
ExAC
TOPMed
gnomAD
COSM301843
rs765421425
CA3061862
61 P>H central_nervous_system [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs765421425
CA105147784
61 P>L No ClinGen
ExAC
gnomAD
CA3061863
rs779009696
61 P>S No ClinGen
ExAC
gnomAD
rs2276959
CA358216808
CA358216807
62 K>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
TCGA novel 63 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs986987347
CA105147219
66 F>S No ClinGen
Ensembl
CA358216559
rs1371153610
69 E>K No ClinGen
TOPMed
rs1351003033
CA358216540
71 D>G No ClinGen
Ensembl
rs1164427987
CA358216504
76 S>L No ClinGen
TOPMed
gnomAD
rs1475232431
CA358216502
77 V>I No ClinGen
gnomAD
rs754580899
CA3061837
78 T>R No ClinGen
ExAC
gnomAD
CA3061835
rs201745396
80 T>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs764598097
CA3061832
81 P>A No ClinGen
ExAC
gnomAD
COSM1753514
rs760685718
CA3061831
84 A>V urinary_tract [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs772455118
CA3061829
91 S>R No ClinGen
ExAC
gnomAD
CA358216402
rs1284245925
92 L>F No ClinGen
TOPMed
gnomAD
CA105147217
rs761571556
92 L>R No ClinGen
Ensembl
CA3061827
rs374038488
97 E>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA105147216
rs918910697
99 R>G No ClinGen
TOPMed
TCGA novel 99 R>W Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1329294369
CA358216311
100 S>G No ClinGen
gnomAD
rs267600004
CA105147215
101 G>E No ClinGen
Ensembl
CA3061823
CA3061825
rs200916360
101 G>R No ClinGen
1000Genomes
ExAC
gnomAD
CA3061824
rs200916360
101 G>W No ClinGen
1000Genomes
ExAC
gnomAD
CA358216288
rs1579309539
102 E>G No ClinGen
Ensembl
CA3061821
rs780716248
103 G>V No ClinGen
ExAC
gnomAD
CA3061802
rs746453625
105 G>V No ClinGen
ExAC
gnomAD
CA3061801
rs779590312
106 D>N No ClinGen
ExAC
TOPMed
gnomAD
rs779590312
CA358216099
106 D>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1352802266
CA358216079
109 P>A No ClinGen
TOPMed
CA358216068
rs1325079912
111 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA105146928
rs765271498
113 Q>R No ClinGen
Ensembl
rs756413099
CA3061797
115 Q>L No ClinGen
ExAC
gnomAD
TCGA novel 116 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358216025
rs1163703774
116 Q>L No ClinGen
Ensembl
CA358216021
rs1281105747
117 I>V No ClinGen
gnomAD
CA358216014
rs1382243489
118 I>V No ClinGen
gnomAD
rs370720714
CA3061795
119 N>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs759701801
CA3061794
120 E>G No ClinGen
ExAC
gnomAD
rs751640973
CA3061793
121 E>G No ClinGen
ExAC
gnomAD
TCGA novel 122 G>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061792
rs766536568
123 T>A No ClinGen
ExAC
gnomAD
rs1426217659
CA358215977
123 T>I No ClinGen
TOPMed
gnomAD
CA358215978
rs1426217659
123 T>S No ClinGen
TOPMed
gnomAD
CA358215975
rs1579307442
124 E>K No ClinGen
Ensembl
CA358215963
rs1410840968
125 L>F No ClinGen
gnomAD
rs187310450
CA3061790
126 F>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1444414089
CA358215952
127 S>A No ClinGen
gnomAD
CA3061789
rs769685092
128 Y>* No ClinGen
ExAC
gnomAD
CA3061788
rs761594189
129 K>Q No ClinGen
ExAC
TOPMed
gnomAD
CA3061787
rs776556518
129 K>R No ClinGen
ExAC
gnomAD
rs768527501
CA3061786
130 G>D No ClinGen
ExAC
gnomAD
rs373846047
CA3061785
131 N>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs373846047
CA105146926
131 N>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1445166259
CA358215908
134 E>* No ClinGen
gnomAD
rs779577543
COSM279416
CA3061784
138 S>L Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs745584498
CA3061782
139 S>C No ClinGen
ExAC
rs778418092
CA3061781
140 S>G No ClinGen
ExAC
gnomAD
rs116184437
CA3061780
140 S>N No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA358215805
rs1379953423
142 P>A No ClinGen
gnomAD
rs1269635189
CA358215797
142 P>L No ClinGen
gnomAD
CA3061778
rs183552860
144 G>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1299349129
CA358215776
144 G>V No ClinGen
gnomAD
rs3733559
CA3061777
145 L>F No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs372523336
CA3061775
146 Y>C No ClinGen
ESP
ExAC
gnomAD
CA105146925
rs368241121
147 Q>H No ClinGen
ESP
rs762925645
CA3061774
149 D>V No ClinGen
ExAC
TOPMed
TCGA novel 150 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs750727519
CA3061773
154 E>K No ClinGen
ExAC
gnomAD
CA358215630
rs765312059
156 D>G No ClinGen
ExAC
gnomAD
TCGA novel 156 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061772
rs765312059
156 D>V No ClinGen
ExAC
gnomAD
rs1414108213
CA358215624
157 T>A No ClinGen
gnomAD
rs1185376149
CA358215592
159 F>Y No ClinGen
gnomAD
CA358215564
rs1243707164
161 V>A No ClinGen
TOPMed
gnomAD
CA358215552
rs1237808985
162 Y>C No ClinGen
TOPMed
CA358215561
rs1217327138
162 Y>D No ClinGen
gnomAD
CA358215559
rs1217327138
COSM732819
162 Y>H lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA3061768
rs760645674
166 T>I No ClinGen
ExAC
gnomAD
CA105146924
rs1023239764
168 E>G No ClinGen
TOPMed
TCGA novel 169 S>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs977775902
CA105146923
170 D>A No ClinGen
Ensembl
TCGA novel 170 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1220563559
CA358215483
172 P>S No ClinGen
gnomAD
CA105146922
rs192856799
173 Y>H No ClinGen
1000Genomes
gnomAD
rs774064376
CA3061764
174 P>H No ClinGen
ExAC
gnomAD
rs745307819
CA3061765
174 P>T No ClinGen
ExAC
gnomAD
rs375928199
CA3061763
176 L>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs748553660
CA3061762
177 P>L No ClinGen
ExAC
TOPMed
gnomAD
rs1305293911
CA358215093
182 V>A No ClinGen
gnomAD
CA358215098
rs1435738412
182 V>I No ClinGen
TOPMed
gnomAD
CA358215082
rs1458755515
183 D>G No ClinGen
gnomAD
CA358215080
rs1458755515
183 D>V No ClinGen
gnomAD
CA105146921
rs201759555
184 V>M No ClinGen
1000Genomes
TOPMed
rs781717177
CA3061761
185 T>I No ClinGen
ExAC
CA3061759
rs747607712
187 L>M No ClinGen
ExAC
TOPMed
gnomAD
CA358215055
rs1407708631
187 L>R No ClinGen
gnomAD
rs201235432
CA3061757
COSM304869
189 R>C large_intestine [Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs201235432
CA105146920
189 R>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3061756
rs747243634
189 R>H No ClinGen
ExAC
TOPMed
gnomAD
rs757434459
CA3061754
191 T>A No ClinGen
ExAC
gnomAD
rs199541505
CA3061753
191 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA358215033
rs1309307300
192 V>A No ClinGen
gnomAD
rs760451470
CA3061751
192 V>I No ClinGen
ExAC
gnomAD
CA105146918
rs1016447774
198 P>Q No ClinGen
Ensembl
rs759106878
CA3061748
198 P>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA358214987
rs1373139377
199 S>N No ClinGen
gnomAD
CA358214980
rs1297231652
200 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
TCGA novel 201 T>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1398872076
CA358214969
202 A>S No ClinGen
TOPMed
TCGA novel 202 A>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs770532994
CA358214962
COSM447296
203 S>C Variant assessed as Somatic; impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA3061746
rs770532994
203 S>F No ClinGen
ExAC
gnomAD
TCGA novel 205 L>M Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA105146917
rs888536024
208 P>H No ClinGen
TOPMed
gnomAD
CA105146916
rs1048350491
209 I>V No ClinGen
TOPMed
gnomAD
CA358214916
rs1468850185
210 Q>H No ClinGen
gnomAD
CA3061745
rs748994984
210 Q>R No ClinGen
ExAC
gnomAD
CA3061744
rs370140240
212 C>Y No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA358214889
rs1178234997
214 V>A No ClinGen
gnomAD
rs1320240771
CA358214878
216 N>Y No ClinGen
TOPMed
CA358214867
rs1579307075
217 K>I No ClinGen
Ensembl
CA3061743
rs202221151
218 E>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs747273592
CA3061742
220 N>D No ClinGen
ExAC
gnomAD
rs780627480
CA3061741
224 L>V No ClinGen
ExAC
gnomAD
CA358214810
rs1239037791
225 C>S No ClinGen
TOPMed
gnomAD
rs1239037791
CA358214809
225 C>Y No ClinGen
TOPMed
gnomAD
CA3061740
rs758786906
226 A>P No ClinGen
ExAC
gnomAD
CA358214804
rs758786906
226 A>S No ClinGen
ExAC
gnomAD
CA3061739
COSM1050517
rs745994635
226 A>V Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
TCGA novel 229 A>T Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1456444162
CA358214769
231 L>R No ClinGen
TOPMed
rs779006019
CA3061738
232 S>N No ClinGen
ExAC
TOPMed
gnomAD
CA3061736
rs754118720
233 A>G No ClinGen
ExAC
gnomAD
CA3061737
rs370864164
233 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs201068063
CA3061735
234 D>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA105146915
rs1007612983
236 A>D No ClinGen
TOPMed
rs1225857134
CA358214724
238 M>R No ClinGen
gnomAD
rs542131284
CA3061734
240 A>T No ClinGen
1000Genomes
ExAC
gnomAD
CA358214701
rs1451278770
241 P>L No ClinGen
gnomAD
rs1451278770
CA358214702
241 P>R No ClinGen
gnomAD
rs371246314
CA3061731
244 G>D No ClinGen
ESP
ExAC
gnomAD
rs139384833
CA3061729
249 P>L No ClinGen
ESP
ExAC
gnomAD
rs762545868
CA3061728
252 F>L No ClinGen
ExAC
gnomAD
CA3061727
rs773001030
253 A>D No ClinGen
ExAC
gnomAD
rs1422307599
CA358214593
257 F>S No ClinGen
TOPMed
CA3061725
rs761126466
COSM447295
258 P>L Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs779264668
CA3061723
259 S>C No ClinGen
ExAC
TOPMed
gnomAD
CA3061724
rs779264668
259 S>F No ClinGen
ExAC
TOPMed
gnomAD
CA358214580
rs779264668
259 S>Y No ClinGen
ExAC
TOPMed
gnomAD
rs1259499797
CA358214570
261 N>D No ClinGen
gnomAD
rs746411172
CA358214556
263 G>C No ClinGen
ExAC
gnomAD
rs779380661
CA3061721
263 G>D No ClinGen
ExAC
gnomAD
rs746411172
CA3061722
263 G>S No ClinGen
ExAC
gnomAD
rs749301679
CA3061719
265 E>A No ClinGen
ExAC
gnomAD
rs201775943
CA3061718
COSM1050514
266 R>C endometrium [Cosmic] No ClinGen
cosmic curated
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs375890636
CA3061717
COSM347640
266 R>H lung Variant assessed as Somatic; 0.0 impact. oesophagus large_intestine [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs201775943
CA105146911
266 R>S No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1579306915
CA358214535
267 S>R No ClinGen
Ensembl
TCGA novel 269 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs752931599
CA3061716
269 Q>P No ClinGen
ExAC
gnomAD
rs754784780
CA3061714
272 P>S No ClinGen
ExAC
gnomAD
rs754784780
CA3061715
272 P>T No ClinGen
ExAC
gnomAD
CA3061713
rs751610469
273 S>P No ClinGen
ExAC
gnomAD
CA105146910
rs917601186
275 K>Q No ClinGen
Ensembl
rs1360993084
CA358214426
277 G>R No ClinGen
gnomAD
CA3061710
COSM1426608
rs372865079
278 R>C Variant assessed as Somatic; 0.0 impact. large_intestine [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs139074901
CA3061709
278 R>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs990534455
CA105146909
280 V>I No ClinGen
Ensembl
CA3061708
rs146190235
281 Y>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3061707
rs146190235
281 Y>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3061706
rs772379451
282 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1428001168
CA358214362
282 S>P No ClinGen
gnomAD
TCGA novel 284 P>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358214330
rs1321669711
285 K>E No ClinGen
TOPMed
rs141599938
CA3061705
285 K>M No ClinGen
ESP
ExAC
gnomAD
rs1014914987
CA105146908
286 V>A No ClinGen
TOPMed
gnomAD
CA3061703
rs771377467
288 I>T No ClinGen
ExAC
gnomAD
rs1265801558
CA358214227
292 C>Y No ClinGen
TOPMed
CA3061701
rs148222810
293 I>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1266853784
CA358214209
293 I>M No ClinGen
TOPMed
gnomAD
rs148222810
CA3061702
293 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
COSM3674088
CA358214179
rs1262015412
295 N>K prostate [Cosmic] No ClinGen
cosmic curated
TOPMed
rs1560602176
CA358214185
295 N>S No ClinGen
Ensembl
CA3061700
rs769894776
296 K>* No ClinGen
ExAC
gnomAD
rs1325413139
CA358214130
299 F>S No ClinGen
TOPMed
gnomAD
TCGA novel 300 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs754730831
CA3061697
301 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs751338399
CA3061696
306 P>S No ClinGen
ExAC
gnomAD
COSM1050512
rs758373774
CA3061694
307 D>N Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
rs143991157
CA105146907
308 T>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs143991157
CA3061693
308 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs149509624
CA105146905
312 F>L No ClinGen
ESP
TOPMed
rs1227119102
CA358213961
313 D>G No ClinGen
TOPMed
CA3061688
rs759909636
314 V>I No ClinGen
ExAC
gnomAD
CA358213949
rs759909636
314 V>L No ClinGen
ExAC
gnomAD
rs1478410315
CA358213915
317 V>I No ClinGen
TOPMed
gnomAD
CA358213903
rs1268822345
318 N>Y No ClinGen
gnomAD
CA3061687
rs774655851
323 M>T No ClinGen
ExAC
gnomAD
CA105146904
rs374886845
324 S>G No ClinGen
Ensembl
CA358213842
rs1216304897
324 S>N No ClinGen
TOPMed
rs1579306746
CA358213832
325 T>I No ClinGen
Ensembl
rs147005679
CA3061684
326 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs893221711
CA105146903
330 T>A No ClinGen
Ensembl
rs202121255
CA3061682
333 R>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1318441090
CA358213779
334 T>A No ClinGen
TOPMed
gnomAD
CA358213780
rs1318441090
334 T>P No ClinGen
TOPMed
gnomAD
rs1282565130
CA358213774
335 K>E No ClinGen
gnomAD
rs201470920
CA3061680
336 E>G No ClinGen
1000Genomes
ExAC
rs775145403
CA105146901
337 E>D No ClinGen
ExAC
gnomAD
rs780039269
CA3061678
338 A>T No ClinGen
ExAC
gnomAD
CA358213734
rs1391081712
340 Q>H No ClinGen
gnomAD
rs1000683992
CA105146900
340 Q>P No ClinGen
Ensembl
CA3061676
rs139006407
341 K>E No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs147317662
CA3061674
341 K>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3061675
rs139006407
341 K>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs756725309
CA3061673
342 T>I No ClinGen
ExAC
gnomAD
rs1273542298
CA358213722
343 V>I No ClinGen
TOPMed
gnomAD
CA105146898
rs553294108
344 E>A No ClinGen
1000Genomes
rs1560602067
CA358213711
344 E>D No ClinGen
Ensembl
rs182647465
CA105146899
344 E>K No ClinGen
1000Genomes
TOPMed
gnomAD
CA358213693
rs1199090260
347 D>G No ClinGen
gnomAD
rs1053333921
CA105146896
CA358213689
348 G>R No ClinGen
TOPMed
gnomAD
TCGA novel 350 I>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs752323006
CA3061669
351 T>K No ClinGen
ExAC
gnomAD
rs763295881
CA3061667
352 D>G No ClinGen
ExAC
TOPMed
gnomAD
COSM1694924
rs766787215
CA3061668
352 D>N skin [Cosmic] No ClinGen
cosmic curated
ExAC
TOPMed
gnomAD
rs937693864
CA105146895
353 V>I No ClinGen
Ensembl
CA3061665
rs765713869
354 F>L No ClinGen
ExAC
gnomAD
CA358213641
rs1560602036
355 V>A No ClinGen
Ensembl
rs1238086552
CA358213639
356 K>E No ClinGen
TOPMed
gnomAD
CA3061663
rs570604236
357 R>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA3061662
rs758168796
357 R>S No ClinGen
ExAC
TOPMed
gnomAD
CA3061661
rs747288288
358 K>R No ClinGen
ExAC
TOPMed
gnomAD
CA358213618
rs775847008
359 G>A No ClinGen
ExAC
TOPMed
gnomAD
CA3061660
rs775847008
359 G>E No ClinGen
ExAC
TOPMed
gnomAD
rs868169962
CA105146893
359 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
Ensembl
NCI-TCGA
CA105146892
rs62325232
363 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs62325232
CA358213594
363 L>V No ClinGen
gnomAD
CA105146891
rs561208343
364 R>L No ClinGen
TOPMed
CA358213589
COSM1694923
rs561208343
364 R>Q skin [Cosmic] No ClinGen
cosmic curated
TOPMed
CA3061658
rs151063601
364 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA358213582
rs1158296235
365 F>C No ClinGen
gnomAD
rs1468930119
CA358213572
367 P>A No ClinGen
gnomAD
TCGA novel 367 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061657
rs778730817
368 V>L No ClinGen
ExAC
gnomAD
CA358213558
rs1439753648
369 S>F No ClinGen
gnomAD
CA3061656
rs757172180
369 S>T No ClinGen
ExAC
gnomAD
rs1364121914
CA358213529
373 K>N No ClinGen
gnomAD
TCGA novel 373 K>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061654
rs777390211
373 K>R No ClinGen
ExAC
TOPMed
gnomAD
rs1424687228
CA358213525
374 V>G No ClinGen
TOPMed
CA3061653
rs755607548
375 T>A No ClinGen
ExAC
gnomAD
CA3061652
rs143734180
375 T>I No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA3061650
rs758772990
380 S>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA358213473
rs1333469582
382 L>V No ClinGen
TOPMed
CA3061649
rs750747993
383 D>V No ClinGen
ExAC
gnomAD
CA358213449
rs1401068327
386 Q>E No ClinGen
TOPMed
rs762425792
CA3061648
386 Q>L No ClinGen
ExAC
gnomAD
rs762425792
CA3061647
386 Q>R No ClinGen
ExAC
gnomAD
rs140044869
CA3061646
389 V>L No ClinGen
1000Genomes
ExAC
gnomAD
rs140044869
CA3061645
389 V>M No ClinGen
1000Genomes
ExAC
gnomAD
CA3061644
rs760832661
390 R>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
rs1370765710
CA358213411
392 D>H No ClinGen
TOPMed
gnomAD
TCGA novel 392 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358213401
rs1333245792
393 G>E No ClinGen
TOPMed
CA358213387
rs1234388047
395 L>H No ClinGen
TOPMed
rs772364164
CA3061642
396 L>I No ClinGen
ExAC
gnomAD
CA3061639
rs774239705
400 N>D No ClinGen
ExAC
gnomAD
CA358213353
rs1317928618
401 V>M No ClinGen
TOPMed
CA105146890
rs919433409
404 I>T No ClinGen
gnomAD
CA358213316
rs1179547208
406 Q>P No ClinGen
TOPMed
gnomAD
CA358213315
rs1179547208
406 Q>R No ClinGen
TOPMed
gnomAD
TCGA novel 409 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061638
rs770609274
410 R>S No ClinGen
ExAC
gnomAD
CA358213280
rs1237977417
411 G>E Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3061637
rs749304815
412 K>E No ClinGen
ExAC
gnomAD
CA358213270
rs1487172901
413 P>S No ClinGen
TOPMed
gnomAD
CA105146889
rs111583710
414 K>R No ClinGen
Ensembl
rs1217104878
CA358213253
415 A>D No ClinGen
gnomAD
CA358213256
rs1287947234
415 A>T No ClinGen
gnomAD
CA3061636
rs777682795
417 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA105146888
rs992511066
417 Y>H No ClinGen
TOPMed
rs769294164
CA3061635
418 L>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs202169296
CA3061633
419 V>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs202169296
CA105146887
419 V>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA105146886
rs745563516
420 R>* Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA3061630
rs201892645
420 R>L No ClinGen
1000Genomes
ExAC
gnomAD
CA3061631
COSM732821
rs201892645
420 R>Q lung Variant assessed as Somatic; 0.0 impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
1000Genomes
ExAC
NCI-TCGA
gnomAD
CA358213220
rs1342974585
422 K>E No ClinGen
gnomAD
TCGA novel 423 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA105146885
rs752598151
424 N>S No ClinGen
TOPMed
rs1182488275
CA358213177
428 A>P No ClinGen
TOPMed
gnomAD
CA358213178
rs1182488275
428 A>T Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
gnomAD
CA358213162
rs1393493365
430 M>T No ClinGen
TOPMed
rs1323350680
CA358213149
432 K>E No ClinGen
TOPMed
TCGA novel 434 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358213125
rs1343956700
435 A>V No ClinGen
TOPMed
rs764632595
CA3061627
436 T>A No ClinGen
ExAC
TOPMed
gnomAD
CA3061626
rs760854927
438 R>K No ClinGen
ExAC
gnomAD
CA3061625
rs752779002
438 R>S No ClinGen
ExAC
gnomAD
rs1488684895
CA358213101
440 T>A No ClinGen
gnomAD
rs767885830
CA3061624
440 T>I No ClinGen
ExAC
TOPMed
gnomAD
CA3061623
rs759848890
443 S>A No ClinGen
ExAC
gnomAD
rs1224119020
CA358213052
445 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA358213058
rs1245187391
445 P>S Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA3061622
rs774420436
446 S>T No ClinGen
ExAC
TOPMed
gnomAD
rs1272330510
CA358213030
448 P>T No ClinGen
gnomAD
CA358212988
rs1267213161
451 T>A No ClinGen
TOPMed
gnomAD
rs770822561
CA3061621
451 T>R No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 452 R>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061619
rs762583822
455 A>V No ClinGen
ExAC
gnomAD
rs1366001298
CA358212897
457 D>E No ClinGen
gnomAD
CA3061617
rs143875438
460 R>C No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3061616
rs747685788
COSM1731982
460 R>H Variant assessed as Somatic; 0.0 impact. NS [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs559657072
CA3061615
461 T>S No ClinGen
1000Genomes
ExAC
gnomAD
rs1330032255
CA358212848
462 C>R No ClinGen
gnomAD
CA3061614
rs768030210
462 C>Y No ClinGen
ExAC
gnomAD
rs778449790
CA3061608
466 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs753230983
CA3061606
467 V>M No ClinGen
ExAC
TOPMed
gnomAD
rs767760684
CA358212770
468 A>S No ClinGen
ExAC
TOPMed
gnomAD
rs767760684
CA3061605
468 A>T No ClinGen
ExAC
TOPMed
gnomAD
rs999356853
CA105146882
468 A>V No ClinGen
Ensembl
CA358212746
rs1196756493
469 W>C No ClinGen
gnomAD
CA3061604
rs755005486
470 L>V No ClinGen
ExAC
gnomAD
rs751807665
CA3061603
472 T>A No ClinGen
ExAC
gnomAD
rs1223491301
CA358212716
472 T>I No ClinGen
gnomAD
TCGA novel 473 Q>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061601
rs762828906
475 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs772951169
CA3061600
476 N>K No ClinGen
ExAC
CA105146881
rs1041408706
477 K>N No ClinGen
TOPMed
rs1367797091
CA358212629
479 C>G No ClinGen
gnomAD
CA358212627
rs1308083026
479 C>Y No ClinGen
gnomAD
TCGA novel 482 K>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1401906645
CA358212586
483 K>E No ClinGen
gnomAD
TCGA novel 484 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1008241793
CA105146880
484 E>D No ClinGen
TOPMed
gnomAD
TCGA novel 486 D>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061597
rs761790156
486 D>V No ClinGen
ExAC
gnomAD
rs768280639
CA3061596
487 D>H No ClinGen
ExAC
TOPMed
gnomAD
rs768280639
CA3061595
487 D>N No ClinGen
ExAC
TOPMed
gnomAD
CA358212484
rs1433565750
490 N>K No ClinGen
gnomAD
CA358212487
rs1177901167
490 N>S No ClinGen
gnomAD
CA3061593
rs775226205
492 D>E No ClinGen
ExAC
TOPMed
gnomAD
CA3061591
COSM1246853
rs749704430
494 K>T oesophagus [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs778325003
CA3061590
496 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs1053021247
CA105146879
497 E>Q No ClinGen
TOPMed
rs756530609
CA3061589
497 E>V No ClinGen
ExAC
gnomAD
rs368469233
CA3061588
498 Q>K No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA358212425
rs1211179158
499 N>D No ClinGen
gnomAD
TCGA novel 500 Q>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1286408531
CA358212386
504 P>Q No ClinGen
TOPMed
rs1316757756
CA358212370
506 I>M No ClinGen
gnomAD
CA358212339
rs1284840141
511 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA105146878
rs1013457950
513 V>F No ClinGen
Ensembl
CA105146877
rs143169450
520 S>R No ClinGen
ESP
TOPMed
CA105146876
rs374404232
520 S>R No ClinGen
ESP
TOPMed
gnomAD
rs147508531
CA3061585
521 Q>K No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA358212230
rs1304587614
526 A>T No ClinGen
gnomAD
CA3061582
rs750619386
526 A>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 528 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061581
rs574941094
531 T>K No ClinGen
1000Genomes
ExAC
gnomAD
rs1269168319
CA358212184
533 K>T No ClinGen
gnomAD
rs761593820
CA3061580
534 G>S No ClinGen
ExAC
gnomAD
TCGA novel 535 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 536 Q>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358212155
rs1421707765
537 P>L No ClinGen
gnomAD
CA105146875
rs866198845
538 G>D No ClinGen
Ensembl
rs555099921
CA105146874
541 Y>F No ClinGen
1000Genomes
rs776554502
CA3061579
542 L>M No ClinGen
ExAC
TOPMed
gnomAD
rs150533956
CA3061578
543 L>M No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA3061575
rs771582859
544 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs1203353850
CA358212109
545 V>A No ClinGen
gnomAD
rs774139448
CA3061574
548 I>L No ClinGen
ExAC
gnomAD
rs770283562
CA3061572
548 I>T No ClinGen
ExAC
gnomAD
rs774139448
CA3061573
548 I>V No ClinGen
ExAC
gnomAD
rs1579306007
CA358212066
552 G>E No ClinGen
Ensembl
rs781733721
CA3061570
553 H>P No ClinGen
ExAC
gnomAD
CA3061569
rs769002924
555 V>I No ClinGen
ExAC
gnomAD
rs1242181568
CA358212041
556 K>R No ClinGen
TOPMed
TCGA novel 558 Q>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA358212018
rs1316060902
559 S>T No ClinGen
TOPMed
rs1296061948
CA358212005
561 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
rs938378748
CA105146873
562 V>A No ClinGen
TOPMed
gnomAD
TCGA novel 563 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA3061565
rs750712579
565 R>G No ClinGen
ExAC
gnomAD
CA3061563
rs757058614
568 C>Y No ClinGen
ExAC
gnomAD

1 associated diseases with Q8TB73

[MIM: 618841]: Hypogonadotropic hypogonadism 25 with anosmia (HH25)

A form of hypogonadotropic hypogonadism, a group of disorders characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone, and no other abnormalities of the hypothalamic-pituitary axis. In some cases, it is associated with non-reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). HH25 is an autosomal dominant form with anosmia, characterized by intrafamilial variable expressivity and incomplete penetrance. {ECO:0000269|PubMed:31883645}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • A form of hypogonadotropic hypogonadism, a group of disorders characterized by absent or incomplete sexual maturation by the age of 18 years, in conjunction with low levels of circulating gonadotropins and testosterone, and no other abnormalities of the hypothalamic-pituitary axis. In some cases, it is associated with non-reproductive phenotypes, such as anosmia, cleft palate, and sensorineural hearing loss. Anosmia or hyposmia is related to the absence or hypoplasia of the olfactory bulbs and tracts. In the presence of anosmia, idiopathic hypogonadotropic hypogonadism is referred to as Kallmann syndrome, whereas in the presence of a normal sense of smell, it has been termed normosmic idiopathic hypogonadotropic hypogonadism (nIHH). HH25 is an autosomal dominant form with anosmia, characterized by intrafamilial variable expressivity and incomplete penetrance. {ECO:0000269|PubMed:31883645}. Note=The disease is caused by variants affecting the gene represented in this entry.

3 regional properties for Q8TB73

Type Name Position InterPro Accession
domain Fibronectin type III 174 - 325 IPR003961-1
domain Fibronectin type III 445 - 554 IPR003961-2
domain Protein NDNF, C-terminal 395 - 568 IPR045805

Functions

Description
EC Number
Subcellular Localization
  • Secreted
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

3 GO annotations of cellular component

Name Definition
extracellular matrix A structure lying external to one or more cells, which provides structural support, biochemical or biomechanical cues for cells or tissues.
extracellular region The space external to the outermost structure of a cell. For cells without external protective or external encapsulating structures this refers to space outside of the plasma membrane. This term covers the host cell environment outside an intracellular parasite.
extracellular space That part of a multicellular organism outside the cells proper, usually taken to be outside the plasma membranes, and occupied by fluid.

2 GO annotations of molecular function

Name Definition
glycosaminoglycan binding Binding to a glycan (polysaccharide) containing a substantial proportion of aminomonosaccharide residues.
heparin binding Binding to heparin, a member of a group of glycosaminoglycans found mainly as an intracellular component of mast cells and which consist predominantly of alternating alpha-(1->4)-linked D-galactose and N-acetyl-D-glucosamine-6-sulfate residues.

14 GO annotations of biological process

Name Definition
angiogenesis Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels.
cellular response to fibroblast growth factor stimulus Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an fibroblast growth factor stimulus.
cellular response to hypoxia Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a stimulus indicating lowered oxygen tension. Hypoxia, defined as a decline in O2 levels below normoxic levels of 20.8 - 20.95%, results in metabolic adaptation at both the cellular and organismal level.
extracellular matrix organization A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of an extracellular matrix.
gonadotrophin-releasing hormone neuronal migration to the hypothalamus The directional movement of a gonadotrophin-releasing hormone producing neuron from the nasal placode to the hypothalamus.
negative regulation of endothelial cell apoptotic process Any process that stops, prevents or reduces the frequency, rate or extent of endothelial cell apoptotic process.
negative regulation of neuron apoptotic process Any process that stops, prevents, or reduces the frequency, rate or extent of cell death by apoptotic process in neurons.
neuron migration The characteristic movement of an immature neuron from germinal zones to specific positions where they will reside as they mature.
nitric oxide mediated signal transduction Any intracellular signal transduction in which the signal is passed on within the cell via nitric oxide (NO). Includes synthesis of nitric oxide, receptors/sensors for nitric oxide (such as soluble guanylyl cyclase/sGC) and downstream effectors that further transmit the signal within the cell. Nitric oxide transmits its downstream effects through either cyclic GMP (cGMP)-dependent or independent mechanisms.
peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan The formation of a cross-link between peptide chains mediated by a chondroitin 4-sulfate glycosaminoglycan that originates from a typical O-glycosidic link to serine of one chain; the other chain is esterified, via the alpha-carbon of its C-terminal Asp, to C-6 of an internal N-acetylgalactosamine of the glycosaminoglycan chain.
positive regulation of cell-substrate adhesion Any process that increases the frequency, rate or extent of cell-substrate adhesion. Cell-substrate adhesion is the attachment of a cell to the underlying substrate via adhesion molecules.
positive regulation of neuron projection development Any process that increases the rate, frequency or extent of neuron projection development. Neuron projection development is the process whose specific outcome is the progression of a neuron projection over time, from its formation to the mature structure. A neuron projection is any process extending from a neural cell, such as axons or dendrites (collectively called neurites).
response to ischemia Any process that results in a change in state or activity of an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a inadequate blood supply.
vascular wound healing Blood vessel formation when new vessels emerge from the proliferation of pre-existing blood vessels and contribute to the series of events that restore integrity to damaged vasculature.

No homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
No homologous proteins
10 20 30 40 50 60
MVLLHWCLLW LLFPLSSRTQ KLPTRDEELF QMQIRDKAFF HDSSVIPDGA EISSYLFRDT
70 80 90 100 110 120
PKRYFFVVEE DNTPLSVTVT PCDAPLEWKL SLQELPEDRS GEGSGDLEPL EQQKQQIINE
130 140 150 160 170 180
EGTELFSYKG NDVEYFISSS SPSGLYQLDL LSTEKDTHFK VYATTTPESD QPYPELPYDP
190 200 210 220 230 240
RVDVTSLGRT TVTLAWKPSP TASLLKQPIQ YCVVINKEHN FKSLCAVEAK LSADDAFMMA
250 260 270 280 290 300
PKPGLDFSPF DFAHFGFPSD NSGKERSFQA KPSPKLGRHV YSRPKVDIQK ICIGNKNIFT
310 320 330 340 350 360
VSDLKPDTQY YFDVFVVNIN SNMSTAYVGT FARTKEEAKQ KTVELKDGKI TDVFVKRKGA
370 380 390 400 410 420
KFLRFAPVSS HQKVTFFIHS CLDAVQIQVR RDGKLLLSQN VEGIQQFQLR GKPKAKYLVR
430 440 450 460 470 480
LKGNKKGASM LKILATTRPT KQSFPSLPED TRIKAFDKLR TCSSATVAWL GTQERNKFCI
490 500 510 520 530 540
YKKEVDDNYN EDQKKREQNQ CLGPDIRKKS EKVLCKYFHS QNLQKAVTTE TIKGLQPGKS
550 560
YLLDVYVIGH GGHSVKYQSK VVKTRKFC